Clinical Trial Update: Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating stereotactic boost therapy for locally advanced non-small cell lung cancer was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Non-small Cell Lung Cancer, Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-09-05